SMAD7 and multiple sclerosis: Microarray analysis revealed that the change in Smad7 expression following treatment with IVMP, in relapsing–remitting in patients with multiple sclerosis (in vivo), was significantly lower than that in CD4+ T cells from healthy donors (in vitro).